SNAI1 drives stem cell properties, metabolic alterations, cancer invasion, and chemoresistance in epithelial ovarian cancer [55], promotes metastasis in breast tumors [56], and high expression of SNAI1 is considered a clinical biomarker in gastric cancer [57]. This evidence concerns the gene SNAI1 and breast neoplasm.